Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-1998 | 09-1998 | 06-1998 | 03-1998 | 12-1997 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 45,720 | 196,120 | 184,240 | 29,660 | 82,830 |
Marketable Securities | 26,920 | 2,920 | 4,360 | 5,540 | 32,100 |
Receivables | 97,220 | 75,230 | 79,220 | 73,050 | 65,040 |
Inventories | 78,780 | 69,940 | 71,500 | 64,510 | 46,960 |
Other current assets | 44,610 | 40,160 | 36,390 | 30,740 | 19,830 |
TOTAL | $293,250 | $384,370 | $375,710 | $203,500 | $246,760 |
Non-Current Assets | |||||
PPE Net | N/A | N/A | N/A | N/A | 135,680 |
Investments And Advances | 193,150 | 153,310 | 149,920 | 116,460 | 131,080 |
Other Non-Current Assets | 474,500 | 357,270 | 359,410 | 362,570 | 289,120 |
TOTAL | $667,650 | $510,580 | $509,330 | $479,030 | $555,880 |
Total Assets | $1,070,040 | $1,000,370 | $982,080 | $775,650 | $754,980 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 980 | 970 | 850 | 850 | 860 |
Accounts payable and accrued liabilities | 63,790 | 66,330 | 72,790 | 64,900 | 44,420 |
Other current liabilities | 30,000 | 30,500 | 30,500 | 50,000 | 45,000 |
TOTAL | $94,780 | $109,170 | $128,070 | $130,190 | $99,840 |
Non-Current Liabilities | |||||
Long Term Debt | 149,870 | 150,090 | 150,610 | 2,170 | 2,380 |
aiOther Non-Current Liabilities | 20,400 | 21,000 | 21,020 | 21,020 | 50,850 |
TOTAL | $224,780 | $207,710 | $208,080 | $49,990 | $90,110 |
Total Liabilities | $319,560 | $316,880 | $336,160 | $180,190 | $189,970 |
Shareholders' Equity | |||||
Common Shares | 290 | 290 | 290 | 290 | 290 |
Retained earnings | 395,860 | 353,450 | 319,620 | 286,860 | 275,030 |
Other shareholders' equity | 60,650 | 37,940 | 37,690 | 23,050 | 33,010 |
TOTAL | $750,470 | $683,480 | $645,920 | $595,460 | $565,010 |
Total Liabilities And Equity | $1,070,030 | $1,000,360 | $982,080 | $775,650 | $754,980 |